Ureteral Cancer: Treatment Options and Patient Concerns - Oncology

Share to:

Ureteral cancer


Hello Dr.
Lai: My mother was diagnosed with stage III ureteral malignant tumor in April of this year.
She has undergone the removal of her left kidney, ureter, and a portion of the bladder.
She is now preparing to undergo chemotherapy.
I would like to ask: 1.
Are there only two chemotherapy drugs currently available for this type of cancer? Do all hospitals use these two chemotherapy drugs? 2.
If she receives treatment at a larger hospital (such as National Taiwan University Hospital or Veterans General Hospital), will there be more advanced techniques available? 3.
Recently, my mother has experienced swelling at the urethral opening and hematuria.
What could be the cause? Could it be an issue with her kidney or bladder again?

errorwu, 30~39 year old female. Ask Date: 2016/06/19

Dr. Lai Yicheng reply Oncology


Dear Ms.
Wu,
1.
You have been diagnosed with urothelial carcinoma, and the standard treatment involves a chemotherapy regimen of Gemcitabine and Cisplatin, which is the first-line therapy and the most effective option available.
2.
The medical center also utilizes this standard medication, and there is currently no urban-rural disparity in treatment.
You should consider your convenience and follow-up care in this decision.
3.
How long after the surgery did you experience swelling at the urethral opening and hematuria? If the symptoms persist, further evaluation is necessary, as the nature of urothelial carcinoma is multifocal.
Wishing you all the best,
Changhua Hospital
Department of Radiation Oncology
Dr.
Lai Yi-Cheng

Reply Date: 2016/06/19

More Info


Ureteral cancer, a type of upper urinary tract cancer, is often challenging to treat due to its location and the potential for aggressive behavior. Your mother's diagnosis of stage III ureteral cancer, along with the surgical intervention she has already undergone, indicates a serious condition that requires careful management. Let's address your questions one by one.

1. Chemotherapy Options: The standard chemotherapy regimen for ureteral cancer typically includes a combination of Gemcitabine and Cisplatin, which are considered first-line treatments. While these are the most commonly used agents, there are other options available depending on the specific characteristics of the cancer and the patient's overall health. For instance, some patients may benefit from other chemotherapeutic agents or combinations, and clinical trials may offer access to newer therapies. It is essential to discuss with your oncologist whether there are additional options available beyond the standard two drugs, as treatment can vary based on individual circumstances.

2. Advanced Techniques in Larger Hospitals: Larger medical centers, such as National Taiwan University Hospital or Veterans General Hospital, often have access to more advanced technologies and treatment protocols. These institutions may offer clinical trials, specialized surgical techniques, and multidisciplinary teams that can provide comprehensive care. While the standard chemotherapy drugs may still be the same, the overall management, including supportive care and monitoring, may be more robust in a larger facility. It is advisable to consider the convenience of follow-up care and the expertise available at these institutions when making your decision.

3. Symptoms of Urinary Distress: The recent symptoms your mother is experiencing, such as swelling at the urethral opening and hematuria (blood in urine), are concerning and warrant immediate medical attention. These symptoms could indicate several issues, including complications from surgery, such as urinary tract infections, or recurrence of cancer. Given the aggressive nature of ureteral cancer, it is crucial to have these symptoms evaluated promptly. A urologist or oncologist should perform a thorough examination, which may include imaging studies or cystoscopy, to determine the underlying cause of these symptoms.

In summary, managing ureteral cancer requires a tailored approach that considers the specific characteristics of the disease and the patient's overall health. It is essential to maintain open communication with your healthcare team, ask questions about treatment options, and express any concerns regarding symptoms. Regular follow-ups and monitoring are crucial for early detection of any complications or recurrence. Your mother's care should be a collaborative effort between her oncologist, urologist, and any other specialists involved in her treatment.

Similar Q&A

Managing Ureteral Tumors in Elderly Patients with Bladder Cancer

Hello Doctor: My mother has stage II bladder cancer along with ureteral cancer. After undergoing endoscopic laser surgery and radiation therapy, the doctor mentioned that there is still a segment of the ureteral tumor that has not been removed. She is scheduled for another endosc...


Dr. Li Xinyi reply Urology
Based on your description, it seems that you are referring to an endoscopic laser tumor vaporization procedure, rather than a resection followed by suturing. Endoscopic surgery is generally considered to be safer than traditional open surgery. It is important to discuss the detai...

[Read More] Managing Ureteral Tumors in Elderly Patients with Bladder Cancer


Early Stage Right Ureter Cancer in Dialysis Patients: Surgical Options

Hello doctor: I am a kidney patient with early-stage right ureter cancer undergoing peritoneal dialysis. Should I have surgery?


Dr. Lin Zongzhe reply Oncology
Hello: The most important treatment method for early-stage ureteral cancer is indeed surgery. The risks associated with the surgery can be assessed by the attending surgeon and the anesthesiologist. This is a response from Dr. Lin Tsung-Che, an oncologist at Taoyuan Hospital, Dep...

[Read More] Early Stage Right Ureter Cancer in Dialysis Patients: Surgical Options


Managing Ureteral Fibrosis and Stricture in Endometrial Cancer Patients

A patient with endometrial cancer has developed ureteral fibrosis and stenosis due to radiation therapy four years ago. Previously, a double-J stent was placed long-term (changed every three months) as a management strategy. However, the patient has recently been hospitalized fre...


Dr. Xu Weikai reply Urology
Hello, currently, the placement of double J ureteral stents is the simplest treatment option. If there are frequent infections or if fibrosis has not been adequately improved, surgical correction may be considered (such as ureteral dilation or reconstruction). If the fibrosis is ...

[Read More] Managing Ureteral Fibrosis and Stricture in Endometrial Cancer Patients


Managing Stage III Renal Pelvis Cancer: Treatment Options for Elderly Patients

Director Du: My father underwent a CT scan that revealed a tumor in the renal pelvis, which was confirmed as renal pelvis cancer through a biopsy. He subsequently had a left nephrectomy and lymphadenectomy near the ureter, and the pathology report indicated stage III renal pelvis...


Dr. Du Shixi reply Urology
Hello: Your father should undergo examination and treatment at a major hospital, as he is already in stage 3. The 5-year survival rate is approximately 50-60%. If his physical condition is good, aggressive treatment can be pursued. However, if his health status is poor, such as l...

[Read More] Managing Stage III Renal Pelvis Cancer: Treatment Options for Elderly Patients


Related FAQ

Bladder Cancer

(Oncology)

Kidney Tumor

(Oncology)

Ureter

(Urology)

Tumor

(Urology)

Rectal Cancer

(Oncology)

Bile Duct Cancer

(Oncology)

Groin

(Oncology)

Radiation Therapy

(Oncology)

Pancreatic Cancer

(Oncology)

Oral Cancer

(Oncology)